Comparative Effectiveness Research

Much of the loud clamoring about the recently passed stimulus health-care provision targets “comparative effectiveness research.” Steven Pearlstein of The Washington Post notes the criticism comes mostly from those with a conservative perspective who believe, or at least profess to believe, that “the market” is supposed to magically keep costs down and health care, like…

Continue reading →

Restricting Drug Access

Dr. Scott Gottlieb’s title of his op-ed column in The Wall Street Journal, “Congress Wants to Restrict Drug Access,” is misleading, not by what it says, but by what it doesn’t say. Dr. Gottlieb does talk about how research on effectiveness of drugs will lead to restriction on what drugs a patient may get, and…

Continue reading →

Show Buttons
Hide Buttons